Related references
Note: Only part of the references are listed.Frequency of HER2 Heterogeneity by Fluorescence In Situ Hybridization According to CAP Expert Panel Recommendations Time for a New Look at How to Report Heterogeneity
Kimberly H. Allison et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2011)
Heterogeneous HER2 Gene Amplification Impact on Patient Outcome and a Clinically Relevant Definition
Alastair I. Bartlett et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2011)
HER2 genetic heterogeneity in breast carcinoma
Christian Oehlschlegel et al.
JOURNAL OF CLINICAL PATHOLOGY (2011)
PTEN, PIK3CA, p-AKT, and p-p70S6K Status Association with Trastuzumab Response and Survival in Patients with HER2-Positive Metastatic Breast Cancer
Francisco J. Esteva et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Accurately Assessing HER-2/neu Status in Needle Core Biopsies of Breast Cancer Patients in the Era of Neoadjuvant Therapy: Emerging Questions and Considerations Addressed
Timothy D'Alfonso et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
Prevalence and Heterogeneity of KRAS, BRAF, and PIK3CA Mutations in Primary Colorectal Adenocarcinomas and Their Corresponding Metastases
Stephan E. Baldus et al.
CLINICAL CANCER RESEARCH (2010)
Intratumoral heterogeneity of HER-2 gene amplification and protein overexpression in breast cancer
Julie M. Wu et al.
HUMAN PATHOLOGY (2010)
Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype
So Yeon Park et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Molecular predictors of response to trastuzumab and lapatinib in breast cancer
Francisco J. Esteva et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
The Clinical Importance of the Heterogeneity of HER2 neu
Enrique Davila et al.
CASE REPORTS IN ONCOLOGY (2010)
Breast tumor heterogeneity: causes and consequences
K. Polyak et al.
BREAST CANCER RESEARCH (2009)
Using a higher cutoff for the percentage of HER2+cells decreases interobserver variability in the interpretation of HER2 immunohistochemical analysis
Omar Hameed et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2008)
Dynamic and modern: Bringing the ethics of phase I trials up to date
D. Ross Camidge et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Intratumoral heterogeneity of HER-2/neu in invasive mammary carcinomas using fluorescence in-situ hybridization and tissue microarray
Sandra J. Shin et al.
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY (2006)
Automated quantitative analysis (AQUA) of in situ protein expression, antibody concentration, and prognosis
A McCabe et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
The apportionment of quadratic entropy:: a useful alternative for partitioning diversity in ecological data
S Pavoine et al.
ENVIRONMENTAL AND ECOLOGICAL STATISTICS (2005)
Marked intratumoral heterogeneity of c-myc and CyclinD1 but not of c-erbB2 amplification in breast cancer
S Glöckner et al.
LABORATORY INVESTIGATION (2002)